Sector News

UnitedHealth adds new C-suite member from Lockheed Martin

November 14, 2019
Life sciences

UnitedHealth Group Inc. has hired Patricia Lewis as its new chief human resources officer. She’ll serve in the office of the chief executive, the company said in an email. She’s replacing D. Ellen Wilson, who is retiring.

Previously, Lewis served in the same role at Lockheed Martin Corp. She’s also worked in human resources for IBM and DuPont.

At Lockheed Martin, Lewis had success starting a number of talent initiatives, including the STEM Scholarship Program and the Program Management Talent Initiative, with the goal of increasing the presence of traditionally underrepresented groups in STEM.

Lewis was recently featured in Politco’s “Women Rule” newsletter under the heading “Wisdom of the Week.” Her wisdom read, in part, “Bold leaders consistently demonstrate courage. Being courageous means taking risks even if you are faced with an uncertain outcome.”

UnitedHealth is Minnesota’s largest public company. In 2018, it had an income of $11.99 billion on $229.48 billion in sales. It employs 18,500 people in Minnesota alone, according to Business Journal research.

By: Carrigan Miller

Source: bizjournals.com

comments closed

Related News

July 21, 2024

CordenPharma invests €900m in peptide platform expansion

Life sciences

CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform. The planned investment consists of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions.

July 21, 2024

DSM-Firmenich to sell MEG-3 fish oil business to KD Pharma Group

Life sciences

DSM-Firmenich has announced the sale of its MEG-3 fish oil business to KD Pharma Group, a contract development and manufacturing organisation that is active in pharmaceutical and nutritional lipids. As part of the transaction, DSM-Firmenich will obtain a minority stake of 29% in KD Pharma’s parent company O³ Holding GmbH.

July 21, 2024

Veranova appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

Life sciences

Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutica l and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer. Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management.

How can we help you?

We're easy to reach